申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20210292300A1
公开(公告)日:2021-09-23
Disclosed are compounds of Formula (I) or a salt thereof, wherein R
1
; R
3
, R
4
, R
5
, m, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.